Correlation Between Instil Bio and Supernus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Instil Bio and Supernus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Instil Bio and Supernus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Instil Bio and Supernus Pharmaceuticals, you can compare the effects of market volatilities on Instil Bio and Supernus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Instil Bio with a short position of Supernus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Instil Bio and Supernus Pharmaceuticals.
Diversification Opportunities for Instil Bio and Supernus Pharmaceuticals
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Instil and Supernus is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Instil Bio and Supernus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Supernus Pharmaceuticals and Instil Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Instil Bio are associated (or correlated) with Supernus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Supernus Pharmaceuticals has no effect on the direction of Instil Bio i.e., Instil Bio and Supernus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Instil Bio and Supernus Pharmaceuticals
Considering the 90-day investment horizon Instil Bio is expected to generate 4.41 times more return on investment than Supernus Pharmaceuticals. However, Instil Bio is 4.41 times more volatile than Supernus Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Supernus Pharmaceuticals is currently generating about 0.09 per unit of risk. If you would invest 2,097 in Instil Bio on November 18, 2024 and sell it today you would earn a total of 204.00 from holding Instil Bio or generate 9.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Instil Bio vs. Supernus Pharmaceuticals
Performance |
| Timeline |
| Instil Bio |
| Supernus Pharmaceuticals |
Instil Bio and Supernus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Instil Bio and Supernus Pharmaceuticals
The main advantage of trading using opposite Instil Bio and Supernus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Instil Bio position performs unexpectedly, Supernus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Supernus Pharmaceuticals will offset losses from the drop in Supernus Pharmaceuticals' long position.| Instil Bio vs. Assembly Biosciences | Instil Bio vs. Nuvation Bio | Instil Bio vs. Achilles Therapeutics PLC | Instil Bio vs. NextCure |
| Supernus Pharmaceuticals vs. Prestige Brand Holdings | Supernus Pharmaceuticals vs. Evotec SE ADR | Supernus Pharmaceuticals vs. Collegium Pharmaceutical | Supernus Pharmaceuticals vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |